FOR vs. OCUL

Last updated Apr 1, 2026

Compare and contrast key facts about Forestar Group Inc. (FOR) and Ocular Therapeutix, Inc. (OCUL).

Performance

FOR vs. OCUL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Forestar Group Inc. (FOR) and Ocular Therapeutix, Inc. (OCUL). The values are adjusted to include any dividend payments, if applicable.

FOR vs. OCUL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
FOR Forestar Group Inc.	-0.77%	-4.98%	-21.62%	114.60%	-29.15%	7.78%	-3.21%	50.54%	-37.05%	65.41%
OCUL Ocular Therapeutix, Inc.	-30.23%	42.15%	91.48%	58.72%	-59.68%	-66.33%	424.05%	-0.75%	-10.56%	-46.83%

Fundamentals

Market Cap FOR : $1.25B OCUL : $1.89B
EPS FOR : $3.27 OCUL : -$1.38
PS Ratio FOR : 0.74 OCUL : 31.49
PB Ratio FOR : 0.70 OCUL : 2.89
Total Revenue (TTM) FOR : $1.69B OCUL : $51.95M
Gross Profit (TTM) FOR : $308.50M OCUL : $45.25M
EBITDA (TTM) FOR : $192.80M OCUL : -$258.96M

Returns By Period

In the year-to-date period, FOR achieves a -0.77% return, which is significantly higher than OCUL's -30.23% return. Over the past 10 years, FOR has outperformed OCUL with an annualized return of 6.42%, while OCUL has yielded a comparatively lower -1.51% annualized return.

FOR

• 1D: 2.00%
• 1M: -14.90%
• YTD: -0.77%
• 6M: -8.09%
• 1Y: 15.61%
• 3Y*: 16.24%
• 5Y*: 0.17%
• 10Y*: 6.42%

OCUL

• 1D: 14.46%
• 1M: -5.26%
• YTD: -30.23%
• 6M: -27.54%
• 1Y: 15.55%
• 3Y*: 17.14%
• 5Y*: -13.42%
• 10Y*: -1.51%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FOR vs. OCUL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FOR

FOR Risk / Return Rank: 56
FOR Sharpe Ratio Rank: 58
FOR Sortino Ratio Rank: 54
FOR Omega Ratio Rank: 51
FOR Calmar Ratio Rank: 59
FOR Martin Ratio Rank: 59

OCUL

OCUL Risk / Return Rank: 50
OCUL Sharpe Ratio Rank: 50
OCUL Sortino Ratio Rank: 53
OCUL Omega Ratio Rank: 52
OCUL Calmar Ratio Rank: 47
OCUL Martin Ratio Rank: 48

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FOR vs. OCUL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Forestar Group Inc. (FOR) and Ocular Therapeutix, Inc. (OCUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FOR	OCUL	Difference
Sharpe ratio Return per unit of total volatility	0.42	0.21	+0.21
Sortino ratio Return per unit of downside risk	0.92	0.91	+0.01
Omega ratio Gain probability vs. loss probability	1.10	1.11	-0.01
Calmar ratio Return relative to maximum drawdown	0.76	0.20	+0.56
Martin ratio Return relative to average drawdown	1.70	0.52	+1.18
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FOR vs. OCUL - Sharpe Ratio Comparison

The current FOR Sharpe Ratio is 0.42, which is higher than the OCUL Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of FOR and OCUL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FOR	OCUL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.42	0.21	+0.21
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.00	-0.17	+0.18
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.17	-0.02	+0.19
Sharpe Ratio (All Time) Calculated using the full available price history	0.00	-0.05	+0.05

Correlation

The correlation between FOR and OCUL is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FOR vs. OCUL - Dividend Comparison

Neither FOR nor OCUL has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

FOR vs. OCUL - Drawdown Comparison

The maximum FOR drawdown since its inception was -89.77%, smaller than the maximum OCUL drawdown of -95.19%. Use the drawdown chart below to compare losses from any high point for FOR and OCUL.

Drawdown Indicators

	FOR	OCUL	Difference
Max Drawdown Largest peak-to-trough decline	-89.77%	-95.19%	+5.42%
Max Drawdown (1Y) Largest decline over 1 year	-20.95%	-57.29%	+36.34%
Max Drawdown (5Y) Largest decline over 5 years	-59.57%	-89.14%	+29.57%
Max Drawdown (10Y) Largest decline over 10 years	-63.45%	-90.94%	+27.49%
Current Drawdown Current decline from peak	-40.02%	-80.43%	+40.41%
Average Drawdown Average peak-to-trough decline	-38.66%	-76.58%	+37.92%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.42%	22.71%	-13.29%

Volatility

FOR vs. OCUL - Volatility Comparison

The current volatility for Forestar Group Inc. (FOR) is 8.63%, while Ocular Therapeutix, Inc. (OCUL) has a volatility of 19.52%. This indicates that FOR experiences smaller price fluctuations and is considered to be less risky than OCUL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FOR	OCUL	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.63%	19.52%	-10.89%
Volatility (6M) Calculated over the trailing 6-month period	25.28%	58.02%	-32.74%
Volatility (1Y) Calculated over the trailing 1-year period	37.15%	75.47%	-38.32%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	37.59%	78.73%	-41.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.56%	80.20%	-42.64%

Financials